VISUAL FIELD DEFECTS SECONDARY TO CABERGOLINE USE IN A PATIENT WITH PITUITARY TUMOR

VISUAL FIELD DEFECTS SECONDARY TO CABERGOLINE USE IN A PATIENT WITH PITUITARY TUMOR

Prolactinoma is the most common functional pituitary macroadenoma. It is usually treated with dopaminergic agonists, among them cabergoline, which decreases tumor size and consequently the symptoms caused by the tumor. An uncommon complication to this treatment is alterations in the visual field. In...

Full description

Bibliographic Details
Main Authors: sylvia andrea araneda, Cristian Marcelo Salgado
Format: Article
Language:English
Published: Pan-American Association of Ophthalmology 2015-02-01
Series:Vision Pan-America
Subjects:
Cabergoline
Adverse effects
Prolactinoma
Visual Fields
Pituitary Neoplasms.
Online Access:http://journals.sfu.ca/paao/index.php/journal/article/view/219
Description
Summary:Prolactinoma is the most common functional pituitary macroadenoma. It is usually treated with dopaminergic agonists, among them cabergoline, which decreases tumor size and consequently the symptoms caused by the tumor. An uncommon complication to this treatment is alterations in the visual field. In the majority of cases, symptoms improve with the discontinuation of the drug. Owing to the diagnostic challenge, we present the following clinical case.
ISSN:2219-4665
2219-4673

Similar Items